Photobiomodulation (PBM) uses specific red and near-infrared (NIR) light wavelengths to modulate cellular respiration. By irradiating target tissue, photons pass through skin layers and reach intracellular chromophores—primarily Cytochrome c Oxidase (CCO) within Complex IV of the mitochondrial electron transport chain.
Mechanism of Action: Dissociation of Inhibitory Nitric Oxide
Under oxidative stress or age-related cellular exhaustion, Nitric Oxide (NO) binds competitively to Cytochrome c Oxidase, displacing oxygen and slowing mitochondrial ATP synthesis. Red light in the 660nm spectrum and near-infrared light at 850nm photo-dissociate NO from CCO, restoring oxygen consumption, boosting cellular membrane potential, and stimulating adenosine triphosphate (ATP) production.
Spectral Wavelength Specifications
- 660nm (Red Wavelength): Absorbed predominantly by superficial skin layers, triggering collagen synthesis, elastin production, and dermal fibroblast migration.
- 850nm (Near-Infrared Wavelength): Penetrates deep tissue up to 5cm, targeting skeletal muscle mitochondria, articular joint cartilage, and vascular endothelium.
- Power Irradiance: High-density dual chip LED canopy emitting >100 mW/cm² at a distance of 6 inches.
- EMF Output: Zero measurable electric/magnetic field emission at treatment distance.
Optimizing Dosing & Photonic Energy Density (Joules/cm²)
Achieving therapeutic responses follows a biphasic dose-response curve (Arndt-Schulz Law). Insufficient photon exposure fails to trigger biological stimulation, whereas excessive power input can induce transient oxidative strain. Recommended clinical dosage is 10–20 Joules/cm² applied 3 to 5 times weekly.
For additional peer-reviewed studies on photobiomodulation dosimetry, consult the NCBI PMC Research Database.